Actin cytoskeleton participation in the onset of IL-1beta induction of an invasive mesenchymal-like phenotype in epithelial MCF-7 cells.

[1]  Kjetil Boye,et al.  S100A4 and metastasis: a small actor playing many roles. , 2010, The American journal of pathology.

[2]  Masahide Takahashi,et al.  Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. , 2009, Cancer letters.

[3]  I. Meza,et al.  Effect of pro-inflammatory cytokine stimulation on human breast cancer: implications of chemokine receptor expression in cancer metastasis. , 2009, Cancer letters.

[4]  Erik Sahai,et al.  The actin cytoskeleton in cancer cell motility , 2009, Clinical & Experimental Metastasis.

[5]  E. Bosco,et al.  Rac1 GTPase: A “Rac” of All Trades , 2009, Cellular and Molecular Life Sciences.

[6]  Gerhard Christofori,et al.  EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.

[7]  Miguel Vicente-Manzanares,et al.  Segregation and activation of myosin IIB creates a rear in migrating cells , 2008, The Journal of cell biology.

[8]  Alberto Mantovani,et al.  Cytokines as a key component of cancer-related inflammation. , 2008, Cytokine.

[9]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[10]  Buzz Baum,et al.  Transitions between epithelial and mesenchymal states in development and disease. , 2008, Seminars in cell & developmental biology.

[11]  M. Zöller,et al.  Tumorigenicity of IL-1α– and IL-1β–Deficient Fibrosarcoma Cells , 2008 .

[12]  M. Macías-Silva,et al.  Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. , 2008, Matrix biology : journal of the International Society for Matrix Biology.

[13]  S. Weed,et al.  Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer , 2008, Clinical & Experimental Metastasis.

[14]  J. Clements,et al.  Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.

[15]  H. Higgs,et al.  The many faces of actin: matching assembly factors with cellular structures , 2007, Nature Cell Biology.

[16]  C. Yip,et al.  The Breast Health Global Initiative: clinical practice guidelines for management of breast cancer in low- and middle-income countries , 2007, Expert review of anticancer therapy.

[17]  Xin Lu,et al.  Organotropism of Breast Cancer Metastasis , 2007, Journal of Mammary Gland Biology and Neoplasia.

[18]  Yoichiro Iwakura,et al.  Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. , 2007, Cancer research.

[19]  B. Aggarwal,et al.  Inflammation and cancer: how hot is the link? , 2006, Biochemical pharmacology.

[20]  Y. Carmi,et al.  The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions , 2006, Cancer and Metastasis Reviews.

[21]  M. Glogauer,et al.  Rac1 links leading edge and uropod events through Rho and myosin activation during chemotaxis. , 2006, Blood.

[22]  S. Somiari,et al.  Circulating MMP2 and MMP9 in breast cancer—Potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories , 2006, International journal of cancer.

[23]  Manuel D. Díaz-Muñoz,et al.  Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells. , 2006, Cellular signalling.

[24]  Y. Changlong,et al.  NF-κBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1β-induced and TNF-α-induced chondrocytes , 2006 .

[25]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[26]  M. Hung,et al.  Cytoplasmic/Nuclear Shuttling and Tumor Progression , 2005, Annals of the New York Academy of Sciences.

[27]  J. Small,et al.  The comings and goings of actin: coupling protrusion and retraction in cell motility. , 2005, Current opinion in cell biology.

[28]  D. Albertson,et al.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.

[29]  A. Mantovani,et al.  Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.

[30]  Xiaoxia Li,et al.  Modulation of Toll–interleukin 1 receptor mediated signaling , 2005, Journal of Molecular Medicine.

[31]  Manfred Schmitt,et al.  Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer , 2004, Thrombosis and Haemostasis.

[32]  R. Panettieri,et al.  Tumor Necrosis Factor α Modulates Airway Smooth Muscle Function via the Autocrine Action of Interferon β* , 2003, Journal of Biological Chemistry.

[33]  P. Hawkins,et al.  Phosphoinositide 3‐kinase‐dependent activation of Rac , 2003, FEBS letters.

[34]  K. Schilling,et al.  Electroporation of primary neural cultures: a simple method for directed gene transfer in vitro , 2002, Histochemistry and Cell Biology.

[35]  Wolfgang Henrich,et al.  The prognostic significance of epithelial-mesenchymal transition in breast cancer. , 2002, Anticancer research.

[36]  W. Stetler-Stevenson,et al.  Proteases in invasion: matrix metalloproteinases. , 2001, Seminars in cancer biology.

[37]  S. Tominaga,et al.  Differential involvement of p38 mitogen-activated protein kinase and phosphatidyl inositol 3-kinase in the IL-1-mediated NF-kappa B and AP-1 activation. , 2001, International immunopharmacology.

[38]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[39]  M. Duffy,et al.  Metalloproteinases: role in breast carcinogenesis, invasion and metastasis , 2000, Breast Cancer Research.

[40]  S. Paludan.  Synergistic action of pro‐inflammatory agents: cellular and molecular aspects , 2000, Journal of leukocyte biology.

[41]  G. Stark,et al.  Activation of Phosphatidylinositol 3-Kinase in Response to Interleukin-1 Leads to Phosphorylation and Activation of the NF-κB p65/RelA Subunit , 1999, Molecular and Cellular Biology.

[42]  J. Schelling,et al.  The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. , 1999, The Journal of clinical investigation.

[43]  G. Bokoch,et al.  Characterization of Rac and Cdc42 Activation in Chemoattractant-stimulated Human Neutrophils Using a Novel Assay for Active GTPases* , 1999, The Journal of Biological Chemistry.

[44]  W. Liao,et al.  Phosphatidylinositol 3-Kinase in Interleukin 1 Signaling , 1997, The Journal of Biological Chemistry.

[45]  H. Hurst,et al.  Transcriptional Regulation of Type I Receptor Tyrosine Kinases in the Mammary Gland , 1997, Journal of Mammary Gland Biology and Neoplasia.

[46]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[47]  M. Kasuga,et al.  Phosphoinositide 3-kinase as an upstream regulator of the small GTP-binding protein Rac in the insulin signaling of membrane ruffling. , 1995, Biochemical and biophysical research communications.

[48]  A. Arcaro,et al.  Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. , 1993, The Biochemical journal.

[49]  M. Gayle,et al.  Interleukin 1 signaling occurs exclusively via the type I receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Guarino.  Epithelial-mesenchymal transition and tumour invasion. , 2007, The international journal of biochemistry & cell biology.

[51]  Y. Changlong,et al.  NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes. , 2006, Osteoarthritis and cartilage.

[52]  A. Hall,et al.  Cell migration: Rho GTPases lead the way. , 2004, Developmental biology.

[53]  R. Panettieri,et al.  Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta. , 2003, The Journal of biological chemistry.

[54]  T D Pollard,et al.  Molecular mechanisms controlling actin filament dynamics in nonmuscle cells. , 2000, Annual review of biophysics and biomolecular structure.

[55]  L. Benítez-Bribiesca,et al.  Proteinase activity in invasive cancer of the breast. Correlation with tumor progression. , 1995, Archives of medical research.

[56]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.